Literature DB >> 17969805

[Sunitinib versus interferon-alpha in metastatic renal-cell carcinoma].

Jacques Irani1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17969805     DOI: 10.1016/s1166-7087(07)92405-7

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


× No keyword cloud information.
  4 in total

1.  Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.

Authors:  Deyao Wu; Xiaobing Niu; Huixing Pan; Yunfeng Zhou; Zichun Zhang; Ping Qu; Jian Zhou
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

2.  In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers.

Authors:  Chuipu Cai; Jiansong Fang; Pengfei Guo; Qi Wang; Huixiao Hong; Javid Moslehi; Feixiong Cheng
Journal:  J Chem Inf Model       Date:  2018-05-10       Impact factor: 4.956

3.  The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.

Authors:  Kaifang Ma; Baoan Hong; Jingcheng Zhou; Yanqing Gong; Jiangyi Wang; Shengjie Liu; Xiang Peng; Bowen Zhou; Jiufeng Zhang; Haibiao Xie; Kenan Zhang; Lei Li; Desheng Cai; Zixin Wang; Lin Cai; Kan Gong
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244

4.  Comparative efficacy and safety of sunitinib vs sorafenib in renal cell carcinoma: A systematic review and meta-analysis.

Authors:  Xiu-Lan Liu; Hui-Ying Xue; Qian Chu; Jin-Yu Liu; Juan Li
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.